FFE: 6UF) (“ NeonMind“), an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions, is pleased to announce that its shares will commence trading on the OTCQB® Venture Market (the “ OTCQB“) on May 28, 2021, under the symbol “NMDBF”. We apologize, but this video has failed to load. Try refreshing your browser. To view an enhanced version of this graphic, please visit: The OTCQB, operated by OTC Markets Group Inc., is designed for early-stage and developing U.S. and international...